We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
30 Jan 2023 - 02 Feb 2023

SBRT Can Safely Treat Multiple Metastatic Tumors

By MedImaging International staff writers
Posted on 03 May 2021
Print article
Image: SBRT can be used to treat multiple metastases (Photo courtesy of University of Chicago)
Image: SBRT can be used to treat multiple metastases (Photo courtesy of University of Chicago)
A new study suggests that stereotactic body radiotherapy (SBRT) can be used effectively for treating patients with multiple metastases.

Researchers at Fox Chase Cancer Center (Philadelphia, PA, USA), the University of Chicago Comprehensive Cancer Center (IL, USA), the University of Michigan (U-M; Ann Arbor, USA), and other institutions conducted a study involving 39 patients (mean age, 63.1; 20 57.1% male; 85.7% White) with breast, prostate, or non-small cell lung cancer (NSCLC), with at least three metastases or two metastases in close proximity. In all, 34.3% had breast cancer, 28.6% had NSCLC, and 37.1% had prostate cancer.

Dose levels were considered safe if dose-limiting toxicity (DLT) levels were observed in no more than one of six patients per location; otherwise, the dose at that location would be de-escalated. The primary end point was DLT related to SBRT within 180 days of treatment. Results of the phase one study showed that at the end of the trial period, primary six-month DLT endpoint was 0%, indicating that the approach was safe enough to begin phase 2/3 clinical trials in a larger group of patients. The study was published on April 22, 2021, in JAMA Oncology.

“People have been saying for years that if we used SBRT in patients with multiple, limited metastases, we could potentially cure more patients. But it's very technically complicated to do so,” said lead author Professor Steven Chmura, MD, PhD, of the University of Chicago. “The greatest challenge was having a whole team of people come together and figure out how we could define the doses and manage the real-time quality assurance to make sure every single patient had the best treatment possible.”

SBRT is emerging as an attractive option for treating cancers in the lung, head and neck, prostate, liver and other disease sites, with the objective of increasing local control of the target lesion while limiting dose to nearby critical structures and normal tissue. Requirements include precise localization of the target lesion in the treatment planning process; accounting for tumor motion due to respiration or other changes in the body; highly conformal dose distribution to the target volume, including a steep dose gradient to minimize radiation to surrounding healthy tissue; and image-guidance at the time of dose delivery for verification and adjustment of the target localization.

Related Links:
Fox Chase Cancer Center
University of Chicago Comprehensive Cancer Center
University of Michigan


Gold Supplier
Ultrasound Transducer/Probe Cleaner
Transeptic Cleaning Solution
New
Premium Ultrasound Scanner
ARIETTA 850
New
Mobile Radiographic Table
CT160
New
Digital Color Doppler Ultrasound
EC100A

Print article
CIRS -  MIRION

Channels

MRI

view channel
Image: BlueSeal magnet for helium-free MR operations (Photo courtesy of Philips)

Use of High-Temperature Superconductors to Make MR Imaging More Affordable, Accessible and Sustainable

A new research partnership focuses on the use of high-temperature superconductors to make MR imaging more affordable, accessible and sustainable in the future. Operating at higher temperatures and eliminating... Read more

Ultrasound

view channel
Image: A combination of ultrasound and nanobubbles allows cancerous tumors to be destroyed without surgery (Photo courtesy of Tel Aviv University)

Ultrasound Combined With Nanobubbles Enables Removal of Tumors Without Surgery

The prevalent method of cancer treatment is surgical removal of the tumor, in combination with complementary treatments such as chemotherapy and immunotherapy. Therapeutic ultrasound to destroy the cancerous... Read more

General/Advanced Imaging

view channel
Image: Ultra-high-resolution photon-counting CT reveals bronchiolectasis (Photo courtesy of Medical University of Vienna)

Photon-Counting CT Shows More Post-COVID-19 Lung Damage

Photon-counting detector (PCD) CT has emerged in the last decade as a promising imaging tool. It works by converting X-ray photons directly into an electrical signal. This avoids the intermediate step... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.